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Abstract 
Vesicular nucleotide transporter (VNUT) is a protein found in insulin granules that facilitates the 
uptake of ATP and release of ATP and insulin. Studies show that suppressed VNUT results in 
reduced insulin secretion. Currently, the regulation of VNUT expression in β cells is unknown. 
The objectives of this study were to determine the effect of high fat diet (HFD) on VNUT levels 
and test if free radicals generated from HFD are involved in HFD modulation of VNUT 
expression in β cells. A mouse insulin-producing cell line (MIN6) was used for this study. The 
control group received growth medium treatment, and the test group received growth medium 
containing fatty acids palmitate, oleate, and linoleate (1:2:1 ratio). The cells were lysed 48 hours 
after treatment, and protein was extracted for western blot analysis for VNUT. To further 
determine the effect of HFD in VNUT expression, adult male mice were fed either a control diet 
or HFD (n=3/group) for one week. We sacrificed the mice and isolated islets from the pancreas 
for protein content. Western blot was run in both models for VNUT expression, normalized 
against the housekeeping gene α-tubulin. Results validated a correlation between HFD and 
reduced VNUT levels compared to control group. Secondly, we introduced the drug BAM15, a 
mitochondrial uncoupler which has been shown to reduce reactive oxygen species production 
from mitochondia. Three trials were conducted with MIN6 cells in the following treatment 
groups: control, HFD, HFD + BAM15, and BAM15 only. After treatment for two days, western 
blot was run to determine VNUT expression. BAM15 showed a trend to restore VNUT levels in 
HFD-fed cells. Additional replications are necessary, as results with the drug were not 
statistically significant. Results of this study and the role of free radicals on modulating VNUT 
expression could have implications for managing diseases where insulin regulation is impaired. 
 
Introduction  
The protein vesicular nucleotide transporter (VNUT) was discovered relatively recently and is 
involved in ATP uptake and release from secretory vesicles including insulin secretory granules 
in pancreatic β cells. After a meal, glucose enters β cells and is metabolized to generate ATP. 
ATP then binds and closes ATP-sensitive potassium channels, which triggers calcium to move 
through calcium channels, ultimately resulting in insulin and ATP secretion from secretory 
vesicles. Recent study has suggested that VNUT resides within insulin granules to modulate 
cellular ATP levels. Previous studies showed that suppression of endogenous VNUT resulted 
directly in a reduction of basal and glucose-induced ATP and insulin release. Likewise, 
overexpression of VNUT resulted in greater ATP release. Thus, this protein could be essential in 
regulating insulin secretion from pancreatic β cells. However, the regulation of VNUT 
expression in β cells is unknown thus far. One possible mechanism by which VNUT is regulated 
involves reactive oxygen species (ROS) as they are generated by the mitochondria in the 
presence of a high energy source. Results of recent experiments indicate a correlation between 
high-fat diets and reduced VNUT expression; therefore, we hypothesized that ROS may 
negatively modulate VNUT levels in pancreatic β cells under nutrient excessive conditions.  
 
Problem Identification and Justification 
Previous studies show that treating pancreatic cells with saturated and unsaturated fatty acids 
results in reduced VNUT expression compared to non-treated cells. It is unknown why a high fat 
diet (HFD) lowers VNUT levels. In order to further study this relationship, it is necessary to gain 
knowledge of the mechanism by which VNUT expression is altered.  
Through this research project, the effect of fatty acid treatment on VNUT was evaluated. 
Understanding the mechanism of VNUT regulation will provide knowledge to manipulate this 
protein and potentially control ATP release and insulin secretion. Knowledge gained from this 
study will have implications for management of diseases such as diabetes where insulin release 
from β cells is impaired or where insulin resistance in cells is an issue. 
 
Hypotheses and Objectives 
 
Previously, western blot analyses on a mouse insulin-producing cell line (MIN6) revealed that 
feeding cells fatty acids reduced VNUT expression. An objective of this study is to validate these 
previous findings in the MIN6 cell line. The level of VNUT present after cells receive fatty acid 
treatment will be measured and compared to controls that receive only the growth medium with 
minimal fatty acids. The hypothesis is that VNUT expression will be reduced by high fat 
treatment compared to cells treated with control media. 
Currently the mechanism underlying the effect of high fat feeding on VNUT expression in β 
cells is unknown. A second objective of this study is to gain a better understanding of the 
possible mechanism by which VNUT expression is regulated. The high energy source from a 
nutrient-rich diet causes the mitochondria to pump out more ATP. In this process, ROS is 
generated. The hypothesis being tested is that free radicals generated from HFD play a role in the 
mechanism to regulate VNUT expression in β cells. If the accumulation of free radicals does 
affect VNUT expression, then treatment of cells with HFD along with compounds that reduce 
ROS production such as drug BAM15, a mitochondrial uncoupler that reduces free radicals, 
should reverse the effect HFD has on VNUT levels.  
 
Procedures and Methodology 
For the first part of this study, cells from a frozen mouse insulin-producing cell line (MIN6) were 
grown in a tissue culture plate and then passaged into additional plates before they reached 
confluence.  These cells were divided into six separate wells (~1x106 cells/well). The wells were 
assigned to either the control group or the test group (n=3 wells/group).  
The control group received cell growth medium (GM) treatment that contained necessary 
nutrients such as vitamins, minerals, and essential amino acids, as well as some glucose and 
phenol red indicator (1:4 dilution of 10% BSA:Gibco®DMEM 1X). The cells in the test group, 
or HFD group, received GM with the addition of palmitate, oleate, and linoleate in a 1:2:1 ratio. 
The control group treatment used 1.2 ml 10%BSA, 4.8 ml GM, and 60µl ethanol to account for 
the additional volume in the treatment group. The HFD treatment used 1.2 ml 10% BSA, 4.8 ml 
GM, and 15µl:30µl:15µl of the respective fatty acids. The control treatment and HFD treatment 
were both filtered separately and 2 ml of the appropriate medium was pipetted into each of 3 
wells for that treatment group. Both groups received treatment for 48 hours in a cell culture 
incubator (held at 37°C and 5% CO2).  
At the end of this incubation period, the old GM was suctioned away and wells were washed 
twice with phosphate buffer (PBS; Gibco®DPBS 1X) solution. The cells in both groups were 
lysed by adding ~200µl of lyse buffer (cocktail of RIPA and protease inhibitor 1:100). The lysate 
from each well was transferred into separate 1.5-ml centrifuge tubes, vortexed, and placed on ice 
for 30 minutes. The tubes were then centrifuged at 4-6°C for 15 minutes at 13,000 rpm. The 
supernatant from each tube was transferred into a new 1.5-ml centrifuge tube.  
Series of protein standards were prepared for the Bradford protein assay in order to calculate the 
protein concentration of each sample. The standard 1st micro-well used 5µl RIPA buffer and 
250µl Quickstart Bradford reagent (room temperature). Each subsequent micro-well contained 
5µl of sample from the respective centrifuge tube and 250µl Bradford reagent. Based on the 
spectrometer readings, calculations were made for preparation of samples with equal protein 
content and volume to be loaded for gel electrophoresis. Appropriate amounts of sample buffer 
(5X SB) and 3µl 1M DTT (as reducing agent) were added to each sample.  
The sample buffer contains glycerol and bromophenol blue tracking dye. 7µl of the protein 
standard and 30µl of each sample were loaded into separate lanes of an SDS-PAGE gel. Gel 
electrophoresis was run to separate the proteins in the lysate by molecular weight. Then, proteins 
in the gel were transferred onto a PVDF membrane via an electric field over 2 hours in a cold 
room. The membrane was washed in TBST washing buffer (Tris-Buffered Saline and Tween 
20), placed into a milk blocking buffer, and placed on a shaker for 30 minutes. 
The membrane was washed with TBST and incubated overnight in the cold room with primary 
antibody anti-ɑ VNUT produced in rabbit (1:1000 dilution; 8µl antibody in 8ml 2.5% milk 
solution). The membrane was then washed and further incubated for 2 hours on a slow shaker 
with secondary antibody anti-rabbit IgG conjugated with HRP (1:5000 dilution). Lastly, Pierce 
ECL Western blotting substrate was added so the antibody-antigen complex could be visualized 
through a digital camera. Image reader software was used to analyze and quantify the amount of 
protein stained on the membrane by optical density. 
The membrane was stripped and re-incubated to test for expression of the housekeeping gene ɑ-
tubulin. For this portion of the study, the primary antibody used was monoclonal anti-mouse 
tubulin (1:4000 dilution), incubated overnight. The secondary antibody was anti-mouse IgG 
conjugated with HRP (1:5000), incubated for 2 hours. Image analysis was conducted, and VNUT 
levels were normalized against tubulin expression. 
The control and HFD treatments were duplicated in an in vivo model as well. Adult male mice 
(weighed between 25-30g; Strain C57BL/6J) were fed either a normal chow diet (Purina 
LabDiet®) or HFD (Research Diets Rodent Diet with 45% kcal %fat) for one week (n=3/group). 
The mice were sacrificed and islets were isolated from the pancreas. Islets were lysed for protein 
analysis, and quantitative western blot analysis was conducted in the same way as was described 
for the in vitro model. 
For the second part of the study, the drug BAM15 was introduced. It has been shown that 
BAM15 functions as a mitochondrial uncoupler to reduce ROS production (Kenwood et al., 
2014). A total of four groups were assigned: control, HFD, HFD + BAM15, and control + 
BAM15. The mitochondrial uncoupler drug was added to the respective treatments in a 1:1000 
dilution (n = 3 wells/group). Cells were lysed after 48 hours of treatment and protein was 
extracted. The same quantitative western blot procedure was followed for the four treatment 
groups as with the first part of the study with two treatment groups. The results from the western 
blot tests indicated the relative amount of VNUT that was present in each group of cells 
receiving the specified treatments.  
Timeline 
During the summer of 2014, the aforementioned experiments were run and test results analyzed. 
More studies into VNUT regulation and HFD modulation of VNUT expression could continue in 
the future. 
 
Findings 
 
The intensity of the band from each western blot test is representative of the amount of VNUT 
within the lysed cell. Results of western blot analyses were compared to see the relative levels of 
VNUT expressed in fat-treated and untreated cells as well as drug-treated cells, with and without 
fat treatment.  
The data from the first part of this experiment validated previous findings that a high-fat diet 
treatment decreases expression of endogenous VNUT in pancreatic β cells for both in vitro (Fig. 
1) and in vivo (Fig. 2) models.  
 
  
 
 
 
 
 
 
 
Furthermore, in the second part of the experiment, BAM15 treatment showed a trend to restore 
VNUT levels in cells fed high fat (Fig. 3). This supports the hypothesis that free radicals are 
involved in HFD modulation of VNUT expression in pancreatic β cells. However, results with 
the drug were not statistically significant. 
 
 
Figure 1: Levels of VNUT in MIN6 β Cells Fed with Control Medium or High 
Fat Medium for 48 Hours 
**: p<0.01 vs HF group 
** 
Figure 2: Levels of VNUT in Islets Isolated from Mice Fed with Chow Diet or 
High Fat Diet for Seven Days 
** 
**: p<0.01 vs HF group 
  
 
 
Future direction for this study would be to replicate the methodology of the four treatment 
groups one or two more times to test for statistical significance (p<0.01 vs HF group). If this is 
determined, the next steps would be publication and studying the effect of BAM15 or similar 
drugs on insulin secretion in animal models fed HFD.  
 
 
 
* 
* 
* 
Figure 3: Effect of BAM15, a Mitochondrial Uncoupler, on VNUT Expression in MIN6 Beta 
Cells Fed with High Fat Medium for 48 Hours 
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